Gender-affirming hormone pharmacokinetics among adolescent and young adult transgender persons receiving daily F/TDF.
Sign Up to like & getrecommendations! Published in 2022 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2022.0044
Abstract: Transgender persons have an increased vulnerability to HIV infection yet have not been well-represented in past clinical trials for pre-exposure prophylaxis (PrEP). Because of this, there are few data available to understand whether gender-affirming hormone… read more here.
Keywords: daily tdf; hormone; affirming hormone; gender affirming ... See more keywords